Related Experiment Video
Updated: Aug 14, 2025

06:22
Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
Published on: August 25, 2020
12.5K
Single-nuclei transcriptomics enable detection of somatic variants in patient brain tissue
Sydney E Townsend1,2, Jesse J Westfall1, Jason B Navarro1
1Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, 43215, USA.
Scientific Reports
|January 11, 2023
Summary
Single-nucleus RNA sequencing can identify somatic variants in brain cells, aiding the study of neurological disorders like focal epilepsies. This method helps determine affected cell types and mutation impacts on gene expression.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Somatic variants contribute to human diseases, including focal epilepsies, but their mosaic nature complicates study.
- Single-cell genomic and transcriptomic data coupling offers potential insights into variant roles in disease.
Purpose of the Study:
- To assess if single-nucleus 3'- or 5'-RNA sequencing can yield genotype data for known variants near transcript ends.
- To evaluate the utility of these methods for studying somatic variants in neurological disorders.
Main Methods:
- Comparison of commercially available single-nucleus 3'- and 5'-RNA sequencing kits.
- Analysis of resected brain samples from three pediatric focal epilepsy patients.
- Quantification of variant detection based on proximity to transcript ends.
Main Results:
- Single-nucleus RNA sequencing effectively detects known somatic variants when they are near transcript ends.
- The study demonstrated successful identification of cell types affected by a RHEB somatic variant in an epilepsy-associated cortical malformation.
- Performance varied based on the distance of the variant from the transcript end.
Conclusions:
- Single-nucleus 3'- or 5'-RNA sequencing is a viable approach for identifying somatic variants in single cells.
- This technique can help elucidate the cellular and molecular mechanisms underlying somatic variant-driven diseases like focal epilepsy.

